1 - 25 of 147 results for author:"Makino H." in Literature citations
Results Customize
› Repeat search in UniProtKB (29)
| Activation of liver X receptor inhibits osteopontin and ameliorates diabetic nephropathy. Tachibana H., Ogawa D., Matsushita Y., Bruemmer D., Wada J., Teshigawara S., Eguchi J., Sato-Horiguchi C., Uchida H.A., Shikata K. et al. J. Am. Soc. Nephrol. 23:1835-1846(2012) · Mapped (11) |
| High frequency of HLA B62 in fulminant type 1 diabetes with the drug-induced hypersensitivity syndrome. Onuma H., Tohyama M., Imagawa A., Hanafusa T., Kobayashi T., Kano Y., Ohashi J., Hashimoto K., Osawa H., Makino H. J. Clin. Endocrinol. Metab. 97:E2277-81(2012) · Mapped (992) |
| Threonine 2609 phosphorylation of the DNA-dependent protein kinase is a critical prerequisite for epidermal growth factor receptor-mediated radiation resistance. Javvadi P., Makino H., Das A.K., Lin Y.F., Chen D.J., Chen B.P., Nirodi C.S. Mol. Cancer Res. 10:1359-1368(2012) · Mapped (21) |
| Spred-2 deficiency exacerbates acetaminophen-induced hepatotoxicity in mice. Wakabayashi H., Ito T., Fushimi S., Nakashima Y., Itakura J., Qiuying L., Win M.M., Cuiming S., Chen C., Sato M. et al. Clin. Immunol. 144:272-282(2012) · Mapped (4) |
| Vaspin is an adipokine ameliorating ER stress in obesity as a ligand for cell-surface GRP78/MTJ-1 complex. Nakatsuka A., Wada J., Iseda I., Teshigawara S., Higashio K., Murakami K., Kanzaki M., Inoue K., Terami T., Katayama A. et al. Diabetes 61:2823-2832(2012) · Mapped (11) |
| Placenta to cartilage: direct conversion of human placenta to chondrocytes with transformation by defined factors. Ishii R., Kami D., Toyoda M., Makino H., Gojo S., Ishii T., Umezawa A. Mol. Biol. Cell 23:3511-3521(2012) · Mapped (18) |
| An in vivo role of bone morphogenetic protein-6 in aldosterone production by rat adrenal gland. Matsumoto Y., Otsuka F., Inagaki K., Tsukamoto N., Takano-Narazaki M., Miyoshi T., Nakamura E., Ogura-Ochi K., Takeda M., Makino H. J. Steroid Biochem. Mol. Biol. 132:8-14(2012) · Mapped (2) |
| Acatalasemic mice are mildly susceptible to adriamycin nephropathy and exhibit increased albuminuria and glomerulosclerosis. Takiue K., Sugiyama H., Inoue T., Morinaga H., Kikumoto Y., Kitagawa M., Kitamura S., Maeshima Y., Wang D.H., Masuoka N. et al. BMC Nephrol 13:14-14(2012) · Mapped (1) |
| Regulatory role of kit ligand-c-kit interaction and oocyte factors in steroidogenesis by rat granulosa cells. Miyoshi T., Otsuka F., Nakamura E., Inagaki K., Ogura-Ochi K., Tsukamoto N., Takeda M., Makino H. Mol. Cell. Endocrinol. 358:18-26(2012) · Mapped (2) |
| Nicorandil as a novel therapy for advanced diabetic nephropathy in the eNOS-deficient mouse. Tanabe K., Lanaspa M.A., Kitagawa W., Rivard C.J., Miyazaki M., Klawitter J., Schreiner G.F., Saleem M.A., Mathieson P.W., Makino H. et al. Am. J. Physiol. Renal Physiol. 302:F1151-60(2012) · Mapped (3) |
| Bone morphogenetic protein-3b (BMP-3b) inhibits osteoblast differentiation via Smad2/3 pathway by counteracting Smad1/5/8 signaling. Matsumoto Y., Otsuka F., Hino J., Miyoshi T., Takano M., Miyazato M., Makino H., Kangawa K. Mol. Cell. Endocrinol. 350:78-86(2012) · Mapped (4) |
| Inhibition of TNF-induced IL-6 by the TWEAK-Fn14 interaction in rheumatoid arthritis fibroblast like synoviocytes. Yamana J., Morand E.F., Manabu T., Sunahori K., Takasugi K., Makino H., Yamamura M. Cell. Immunol. 272:293-298(2012) · Mapped (9) |
| RXR antagonism induces G0 /G1 cell cycle arrest and ameliorates obesity by up-regulating the p53-p21(Cip1) pathway in adipocytes. Nakatsuka A., Wada J., Hida K., Hida A., Eguchi J., Teshigawara S., Murakami K., Kanzaki M., Inoue K., Terami T. et al. J. Pathol. 226:784-795(2012) · Mapped (33) |
| CCN6 as a profibrotic mediator that stimulates the proliferation of lung fibroblasts via the integrin beta1/focal adhesion kinase pathway. Batmunkh R., Nishioka Y., Aono Y., Azuma M., Kinoshita K., Kishi J., Makino H., Kishi M., Takezaki A., Sone S. J. Med. Invest. 58:188-196(2011) · Mapped (13) |
| Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-alpha. Takano M., Otsuka F., Matsumoto Y., Inagaki K., Takeda M., Nakamura E., Tsukamoto N., Miyoshi T., Sada K.E., Makino H. Mol. Cell. Endocrinol. 348:224-232(2012) · Mapped (6) |
| Localization of cytochrome P4502E1 enzyme in normal and cancerous gastric mucosa and association with its genetic polymorphism in unoperated and remnant stomach. Kato S., Naito Z., Matsuda N., Onodera H., Sakurazawa N., Yamashita N., Kanazawa Y., Fujita I., Makino H., Uchida E. J Nippon Med Sch 78:224-234(2011) · Mapped (10) |
| Involvement of MAPKs in ICAM-1 expression in glomerular endothelial cells in diabetic nephropathy. Watanabe N., Shikata K., Shikata Y., Sarai K., Omori K., Kodera R., Sato C., Wada J., Makino H. Acta Med. Okayama 65:247-257(2011) · Mapped (9) |
| Interaction between gonadotropin-releasing hormone and bone morphogenetic protein-6 and -7 signaling in LbetaT2 gonadotrope cells. Takeda M., Otsuka F., Takahashi H., Inagaki K., Miyoshi T., Tsukamoto N., Makino H., Lawson M.A. Mol. Cell. Endocrinol. 348:147-154(2012) · Mapped (3) |
| Blockade of Th1 chemokine receptors ameliorates pulmonary granulomatosis in mice. Kishi J., Nishioka Y., Kuwahara T., Kakiuchi S., Azuma M., Aono Y., Makino H., Kinoshita K., Kishi M., Batmunkh R. et al. Eur. Respir. J. 38:415-424(2011) · Mapped (4) |
| Amelioration of renal alterations in obese type 2 diabetic mice by vasohibin-1, a negative feedback regulator of angiogenesis. Saito D., Maeshima Y., Nasu T., Yamasaki H., Tanabe K., Sugiyama H., Sonoda H., Sato Y., Makino H. Am. J. Physiol. Renal Physiol. 300:F873-86(2011) · Mapped (3) |
| Phase I/IIa clinical trial of therapeutic angiogenesis using hepatocyte growth factor gene transfer to treat critical limb ischemia. Morishita R., Makino H., Aoki M., Hashiya N., Yamasaki K., Azuma J., Taniyama Y., Sawa Y., Kaneda Y., Ogihara T. Arterioscler. Thromb. Vasc. Biol. 31:713-720(2011) · Mapped (5) |
| Intercellular adhesion molecule-1 plays a critical role in glomerulosclerosis after subtotal nephrectomy. Kido Y., Ogawa D., Shikata K., Sasaki M., Nagase R., Okada S., Usui Kataoka H., Wada J., Makino H. Clin. Exp. Nephrol. 15:212-219(2011) · Mapped (13) |
| P-selectin glycoprotein ligand-1 deficiency is protective against obesity-related insulin resistance. Sato C., Shikata K., Hirota D., Sasaki M., Nishishita S., Miyamoto S., Kodera R., Ogawa D., Tone A., Kataoka H.U. et al. Diabetes 60:189-199(2011) · Mapped (11) |
| A novel antagonistic effect of the bone morphogenetic protein system on prolactin actions in regulating steroidogenesis by granulosa cells. Nakamura E., Otsuka F., Inagaki K., Miyoshi T., Yamanaka R., Tsukamoto N., Suzuki J., Ogura T., Makino H. Endocrinology 151:5506-5518(2010) · Mapped (8) |
| Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in C2C12 cells. Matsumoto Y., Otsuka F., Takano M., Mukai T., Yamanaka R., Takeda M., Miyoshi T., Inagaki K., Sada K.E., Makino H. Mol. Cell. Endocrinol. 325:118-127(2010) · Mapped (2) |